{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"The Healthy Enterprise","title":"90% of Drug Developments Fail — Why That's About to Change!","html":"","width":"100%","height":180,"duration":2780,"description":"In this episode, Shashi Ramaiah discusses how outdated drug development practices and regulatory complexity can slow innovation and delay patient access to new therapies. He explains how SPECCRO combines traditional drug development expertise with emerging technologies such as AI, machine learning, organoids, and advanced in vitro models to improve decision-making, reduce risk, and accelerate development timelines. The conversation explores the challenges facing biotech startups, the importance of practical problem-solving, and how collaboration and new technologies are helping shape the future of medicine.Chapters:00:00 The Challenge of Drug Development04:00 Bridging Innovation and Regulation08:43 Integrating New Approaches in Drug Development12:28 The Role of Speccro in Drug Development18:40 Building a Team and Client Relationships23:23 Leveraging Technology and Data28:18 Onboarding Clients and Problem Solving31:28 Future Aspirations and Resilience in StartupsGuest Information:Guest's Name: Shashi Ramaiah Guest's Title/Position: Founder & CEO LinkedIn: https://www.linkedin.com/in/shashi-ramaiah/ Company / Affiliation: SPECCRO https://speccro.com/Guest's Bio: Shashi Ramaiah is a drug development executive, scientist, and entrepreneur with deep expertise in preclinical safety, translational pharmacology, toxicology, and regulatory science. He has authored more than 75 peer-reviewed publications and has led drug development programs across academia, biotech, and the pharmaceutical industry. As Founder and CEO of SPECCRO, Shashi is advancing a modern approach to drug development by combining scientific expertise with innovative tools such as New Approach Methodologies (NAMs), advanced in vitro systems, and AI-driven technologies. Through SPECCRO, he helps organizations accelerate development, improve clinical translation, and bring safer therapies to patients more efficiently. Takeaways:Traditional animal models often fail to reflect human biology.There is a need...","thumbnail_url":"https://img.transistorcdn.com/WKku9MQ84q-0q9Awqd5xdS4eoTolo1ocic6_1x8xlF0/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9mMjI4/MDliNWYyM2MxYWFi/NTkwZmIwNzJkYjk2/YjliMy5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}